Last updated 2026-07-26
- Raised $2.6M grant, Apr 2024
- Raised $2.5M Series A led by Tnuva, Aug 2022
- Raised $1.3M Seed round led by Fresh Start, Sep 2021
Total raised
$6.3M
Last: Undisclosed Round 2024-07
Stage
Seed
Founded
2021
Headcount
20
HQ
Qiryat Shemona, Israel
Sector
Agriculture & Food Technologies
About
ProFuse Technology is an Israeli biotechnology company founded in 2021, based on research from the Weizmann Institute of Science. Initially focused on cultivated meat, the company has expanded its focus to drug discovery for muscle and metabolic health. They leverage a proprietary high-throughput human skeletal muscle platform to identify novel muscle-targeted compounds and develop first-in-class drugs and dietary supplements. ProFuse also provides advanced muscle cell lines and differentiation media supplements to enhance muscle growth, increase yield, accelerate production cycles, and reduce costs in the cultivated meat industry. The company has received grants from the European Innovation Council and the Israel Innovation Authority.
Funding history · 4 rounds · $6.3M total
2024-06
B Round
Undisclosed
★ OurCrowd
2024-04
Grant
$2.6M
2022-08
A Round
$2.5M
★ Tnuva★ Kayma★ Tempo★ OurCrowd★ Siddhi Capital★ Green Circle Foodtech Ventures
2021-09
Seed
$1.3M
★ Fresh StartOurCrowdIsrael Innovation Authority
Headcount over time
From 4 (2021-10) to 20 (2026-03) · +16 (+400%) · 26 points · source: Finder history + radar grounding
Q&A
- What is ProFuse Technology's primary focus?
- ProFuse Technology is a biotechnology company focused on muscle and metabolic health, developing therapeutics and dietary supplements for muscle loss and metabolic conditions. They also offer solutions for cultivated meat production.
- When was ProFuse Technology founded?
- ProFuse Technology was founded in June 2021, based on research from the Weizmann Institute of Science.
- How many employees does ProFuse Technology currently have?
- ProFuse Technology has 11-50 employees.
- What was ProFuse Technology's most recent grant funding?
- In May 2024, ProFuse Technology received a grant of $2,592,000 from the European Innovation Council (EIC) Transition program.
- Which investors participated in ProFuse Technology's Seed round in September 2022?
- In September 2022, ProFuse Technology secured Seed funding with participation from.
- What is ProFuse Technology's total raised capital to date?
- ProFuse Technology has raised a total of $8,000,000 USD.
- What is ProFuse Technology's strategic direction regarding drug discovery?
- In April 2025, ProFuse Technology launched a new drug discovery platform for the prevention of muscle loss, expanding its focus beyond cultivated meat to drug discovery for muscle and metabolic health.
- What is the company's approach to cultivated meat production?
- ProFuse Technology provides advanced muscle cell lines and differentiation media supplements to enhance muscle growth, increase yield, accelerate production cycles, and reduce costs in the cultivated meat industry.
Team · 4
Guy Nevo Michrowski
Founder · Co-Founder and CEO
Dr. Tamar Eigler-Hirsh
Founder · Co-Founder and CTO
Professor Eldad Tzahor
Founder · Co-Founder
Dr. Uri Avinoam
Founder · Co-Founder
Sectors & technology
Primary sector
Agriculture & Food Technologies
Sub-sectors
Climate TechFood & Land UseSustainable ProteinsAgriculture & Food TechnologiesFood TechNovel Food & Ingredients
Technologies
BiologicalsCells
Target customers
Agriculture & FoodLivestockBeef
Business model
B2B
Highlights
Verified
Tags
patent-pendingalternative-proteinfoodtechsustainable-proteinsclimate-tech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | profuse-tech.com/ |
|---|---|
| linkedin.com/company/79932996 |
Identifiers & details
| Founded | 2021-6 |
|---|---|
| Employees (exact) | 20 |
Radar intelligence
Web history (Wayback)
| Domain | profuse-tech.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|